94 related articles for article (PubMed ID: 29561922)
1. The presence of Interleukin-13 in nasal lavage may be a predictor of nasal polyposis in pediatric patients with cystic fibrosis.
Manji J; Thamboo A; Tacey M; Garnis C; Chadha NK
Rhinology; 2018 Sep; 56(3):261-267. PubMed ID: 29561922
[TBL] [Abstract][Full Text] [Related]
2. Use of the SNOT-22 and UPSIT to appropriately select pediatric patients with cystic fibrosis who should be referred to an otolaryngologist: cross-sectional study.
Thamboo A; Santos RC; Naidoo L; Rahmanian R; Chilvers MA; Chadha NK
JAMA Otolaryngol Head Neck Surg; 2014 Oct; 140(10):934-9. PubMed ID: 25144751
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D₃ deficiency and its association with nasal polyposis in patients with cystic fibrosis and patients with chronic rhinosinusitis.
Konstantinidis I; Fotoulaki M; Iakovou I; Chatziavramidis A; Mpalaris V; Shobat K; Markou K
Am J Rhinol Allergy; 2017 Nov; 31(6):395-400. PubMed ID: 29122084
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis and management of nasal polyposis in cystic fibrosis.
Mainz JG; Koitschev A
Curr Allergy Asthma Rep; 2012 Apr; 12(2):163-74. PubMed ID: 23520643
[TBL] [Abstract][Full Text] [Related]
5. Cytokines profile in cystic fibrosis patients with nasal polyps.
Nunes FB; Becker CG; Becker HM; Araujo RN; Guimarães RE
Rev Laryngol Otol Rhinol (Bord); 2009; 130(3):163-7. PubMed ID: 20345072
[TBL] [Abstract][Full Text] [Related]
6. Nasal polyps in patients with and without cystic fibrosis: a differentiation by innate markers and inflammatory mediators.
Claeys S; Van Hoecke H; Holtappels G; Gevaert P; De Belder T; Verhasselt B; Van Cauwenberge P; Bachert C
Clin Exp Allergy; 2005 Apr; 35(4):467-72. PubMed ID: 15836755
[TBL] [Abstract][Full Text] [Related]
7. Cell and cytokine profile in nasal secretions in cystic fibrosis.
Bergoin C; Gosset P; Lamblin C; Bolard F; Turck D; Tonnel AB; Wallaert B
J Cyst Fibros; 2002 Sep; 1(3):110-5. PubMed ID: 15463816
[TBL] [Abstract][Full Text] [Related]
8. Predictors of sinonasal disease onset, progression, and severity in pediatric cystic fibrosis patients.
Weinstock MS; Shaffer AD; Stapleton AL
Am J Otolaryngol; 2021; 42(5):103016. PubMed ID: 33836483
[TBL] [Abstract][Full Text] [Related]
9. Nasal lavage microbiome, but not nasal swab microbiome, correlates with sinonasal inflammation in children with cystic fibrosis.
Chung J; Boutin S; Frey DL; Joachim C; Mall MA; Sommerburg O
J Cyst Fibros; 2024 Mar; 23(2):226-233. PubMed ID: 38199892
[TBL] [Abstract][Full Text] [Related]
10. Nasal lavage levels of granulocyte-macrophage colony-stimulating factor and chronic nasal hypereosinophilia.
De Corso E; Baroni S; Lucidi D; Battista M; Romanello M; Autilio C; Morelli R; Di Nardo W; Passali GC; Sergi B; Bussu F; Fetoni AR; Zuppi C; Paludetti G
Int Forum Allergy Rhinol; 2015 Jun; 5(6):557-62. PubMed ID: 25821067
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis and management of nasal polyposis in cystic fibrosis.
Mainz JG; Koitschev A
Curr Allergy Asthma Rep; 2012 Apr; 12(2):163-74. PubMed ID: 22350539
[TBL] [Abstract][Full Text] [Related]
12. Cytokine profile in subjects with Cystic Fibrosis and nasal polyposis compared to patients with no nasal disorders.
Nunes FB; Castro MC; Silva TM; Araújo RN; Becker HM; Crosara PF; Guimarães RE
Braz J Otorhinolaryngol; 2010; 76(1):25-8. PubMed ID: 20339685
[TBL] [Abstract][Full Text] [Related]
13. Massive nasal polyposis in a patient with newly diagnosed cystic fibrosis.
Olszowiec-Chlebna M; Trzciński K; Stelmach I
Adv Respir Med; 2017; 85(2):121-123. PubMed ID: 28440538
[TBL] [Abstract][Full Text] [Related]
14. Ibuprofen therapy and nasal polyposis in cystic fibrosis patients.
Lindstrom DR; Conley SF; Splaingard ML; Gershan WM
J Otolaryngol; 2007 Oct; 36(5):309-14. PubMed ID: 17963671
[TBL] [Abstract][Full Text] [Related]
15. Detection of cytokines in nasal lavage samples of patients with cystic fibrosis: comparison of two different cytokine detection assays.
Fuchs T; Zlamy M; Zöggeler T; Appelt D; Niedermayr K; Siedl A; Gasser V; Eder J; Ellemunter H
BMC Pulm Med; 2024 Jun; 24(1):286. PubMed ID: 38890643
[TBL] [Abstract][Full Text] [Related]
16. [Expressions of immunoglobulin E, interleukin-5 and granulocyte-macrophage colony-stimulation factor in nasal polyps tissue].
Cao Z; Lü H
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 May; 18(5):276-8. PubMed ID: 15311508
[TBL] [Abstract][Full Text] [Related]
17. Is nasal polyposis in cystic fibrosis a direct manifestation of genetic mutation or a complication of chronic infection?
De Gaudemar I; Contencin P; Van den Abbeele T; Munck A; Navarro J; Narcy P
Rhinology; 1996 Dec; 34(4):194-7. PubMed ID: 9050094
[TBL] [Abstract][Full Text] [Related]
18. Chronic infection with Pseudomonas aeruginosa in cystic fibrosis: a risk factor for nasal polyposis after lung transplantation.
Vital D; Holzmann D; Boehler A; Hofer M
Transplantation; 2013 Jun; 95(12):1548-53. PubMed ID: 23624545
[TBL] [Abstract][Full Text] [Related]
19. Colonization of CF patients' upper airways with S. aureus contributes more decisively to upper airway inflammation than P. aeruginosa.
Janhsen WK; Arnold C; Hentschel J; Lehmann T; Pfister W; Baier M; Böer K; Hünniger K; Kurzai O; Hipler UC; Mainz JG
Med Microbiol Immunol; 2016 Oct; 205(5):485-500. PubMed ID: 27377929
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase 2 and lipoxin A₄ in nasal polyps in cystic fibrosis.
Rozsasi A; Heinemann A; Keck T
Am J Rhinol Allergy; 2011; 25(6):e251-4. PubMed ID: 22185734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]